HUM Humana Inc.

Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study

Humana Pharmacy, a division of (NYSE: HUM), received the highest ranking in Mail Order Pharmacy customer satisfaction for the fourth year in a row in the J.D. Power 2021 U.S. Pharmacy Study.

This press release features multimedia. View the full release here:

Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study (Photo: Business Wire)

Humana Ranks #1 for Customer Satisfaction for Mail Order for Four Consecutive Years in J.D. Power U.S. Pharmacy Study (Photo: Business Wire)

With a score of 906 out of 1,000, Humana ranked first in all four of the study’s Mail Order Pharmacy categories: prescription ordering and filling process, cost competitiveness, prescription delivery, and customer service experience.

“We are grateful to again receive this prestigious honor and to be recognized as #1 year-after-year since 2018. Much of our success can be attributed to Humana’s integrated care strategy, which focuses on improving quality of care and achieving better health outcomes,” said Scott Greenwell, President, Humana Pharmacy Solutions. “Humana Pharmacy takes pride in providing a hassle and worry-free experience as we bring the pharmacy to our customers, shipping medications both safely and on-time. We are always looking for ways to improve our customers’ pharmacy experience. We recently added an autofill program to help make it easier to refill their prescriptions, and we also offer a 90-day supply of medications at one time.”

Greenwell said, “From therapy regimens to questions about quality of life, our experienced pharmacists and support staff are a 24/7 resource to our customers. Not only do our pharmacists dispense medications and monitor treatments, they offer real-time solutions to side effects and have the expertise in both chronic and complex conditions to help customers achieve their best health.”

For more information about Humana Pharmacy, visit . For more information about J.D. Power and the award, visit .

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience with the goal of making health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at , including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information.

EN
28/07/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Moody's Ratings rates Humana’s junior subordinated notes at Baa3 (hyb)

New York , March 5, 2026 - Moody's Ratings (Moody's) has assigned a Baa3 (hyb) rating to Humana Inc.'s (Humana; NYSE: HUM; senior unsecured debt rated Baa2) proposed issuance of up to $1.25 billion of junior subordinated notes. The notes will be issued under the company's existing shelf registration...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 28, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 25, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody’s Ratings announces completion of a periodic review of ratings o...

New York , October 24, 2025 – Moody's Ratings (Moody's) has completed a periodic review of the ratings of Humana Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 22 October 2025 in which we reassessed the appropriateness of the ...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch